Testsealabs Malaria Ag Pan Test

Short Description:

The Malaria Ag Pan Test is a rapid chromatographic immunoassay for the qualitative detection of plasmodium lactate dehydrogenase (pLDH) in whole blood to aid in the diagnosis of malaria (Pan).
gou Rapid Results: Lab-Accurate in Minutes gou Lab-Grade Precision: Reliable & Trustworthy
gou Test Anywhere: No Lab Visit Required  gouCertified Quality: 13485, CE, Mdsap Compliant
gou Simple & Streamlined: Easy-to-Use, Zero Hassle  gou Ultimate Convenience: Test Comfortably at Home

 


Product Detail

Product Tags

HangZhou-Testsea-biotechnology-Co-Ltd- (1)
bb1a88e813d6f76bcea8c426dd670126

Malaria Ag Pan Test

Product Description

 

The Malaria Ag Pan Test is an advanced, rapid chromatographic immunoassay designed for the qualitative detection of Plasmodium-specific antigens in human whole blood. This test simultaneously identifies pan-malarial antigens (common to all Plasmodium species) and Plasmodium falciparum-specific antigens (HRP-II), enabling differential diagnosis of malaria species. It serves as a critical frontline tool for confirming acute malaria infection, guiding timely clinical management, and supporting epidemiological surveillance in endemic regions.

Key Features & Specifications:

  1. Target Analytes:

 

  • Pan-malarial Antigen (pLDH): Detects Plasmodium vivax, ovale, malariae, and knowlesi.
  • Plasmodium falciparum-Specific Antigen (HRP-II): Confirms falciparum infections.

 

  1. Sample Compatibility:

 

  • Whole blood (venous or fingerstick), with optimized performance for fresh, unprocessed samples.

 

  1. Methodology:

 

  • Utilizes dual-antibody sandwich immunoassay technology with colloidal gold nanoparticles for visual signal amplification.
  • Results are interpreted via distinct test lines (T1 for pan-malarial, T2 for P. falciparum) and a control line (C) for procedural validity.

 

  1. Performance Metrics:

 

  • Sensitivity: >99% for P. falciparum; >95% for non-falciparum species at parasitemia levels ≥100 parasites/μL.
  • Specificity: >98% cross-reactivity exclusion against other febrile illnesses (e.g., dengue, typhoid).
  • Time-to-Result: 15 minutes at room temperature (15–30°C).

 

  1. Clinical Utility:

 

  • Aids in differential diagnosis of falciparum vs. non-falciparum malaria.
  • Supports early intervention in acute symptomatic patients (>95% accuracy within 7 days of symptom onset).
  • Complements microscopy/PCR in resource-limited settings.

 

  1. Regulatory & Quality:

 

  • CE-marked and WHO-prequalified.
  • Stable at 4–30°C (24 months shelf life).
HangZhou-Testsea-biotechnology-Co-Ltd- (3)
HangZhou-Testsea-biotechnology-Co-Ltd- (2)
5
  • Send your message to us:

    Send your message to us:

    Write your message here and send it to us